ArticleRMD open2021

Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL.

Katerina Chatzidionysiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.